Phost'in Therapeutics

Kodikaz Therapeutic Solutions

This deep-tech company develops a non-viral delivery platform for cell-specific gene therapies to treat cancer patients.

Type6 Therapeutics

This deep-tech company develops kinase inhibitors for cancer treatment, intercepting enzymes in their inactive states to address drug resistance for patients with aggressive tumours.

Granza Bio

This deep-tech company develops attack particle medicines to treat patients with cancer, autoimmune diseases and infections.

PROSION

This deep-tech company develops small molecule inhibitors to target undruggable proteins for patients with cancer and other serious diseases.

Tubulis

This deep-tech company develops antibody-drug conjugates to treat patients with solid tumours.

PanTher Therapeutics

This deep-tech company develops polymer-based drug delivery systems for continuous, localised chemotherapy treatment for patients with solid tumours, specifically pancreatic cancer.

ParcelBio

This deep-tech firm develops mRNA delivery technologies and programmable medicines for biotechnology and pharmaceutical organisations to treat autoimmune diseases and oncology.

Engimmune Therapeutics

This deep-tech company develops soluble T-cell receptor drugs for healthcare providers to treat patients with solid tumour cancers and immune-mediated diseases.